(1) Kawabata Y, Wada K, Nakatani M, Yamada S and Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int. J. of Pharm.(2011) 420: 1-10.
(2) Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv. Drug Deliv. Rev. (2012) 64: 480-495.
(3) Wei H and Lobenberg R. Biorelevant dissolution media as a predictive tool for glyburide a class II drug. Eur. J. of Pharm. Sci. ( 2006) 29: 45-52.
(4) Vo CLN, Park C and Lee B. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur. J. of Pharm. and Biopharm.( 2013) 85: 799-813.
(5) Rane Y, Mashru R, Sankalia M and Sankalia J. Effect of Hydrophilic Swellable Polymers on Dissolution Enhancement of Carbamazepine Solid Dispersions Studied Using Response Surface Methodology. AAPS Pharm.Sci.Tech. (2007) 8:E1- E11.
(6) Abd-El Bary A, Louis D and Sayed S. Olmesartan medoxomil surface solid dispersion-based orodispersible tablets: formulation and in vitro characterization. J. of Drug Deliv. Sci. & Technol.(2014) 24: 665-672.
(7) Shamma RN and Basha M. Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder Technol. (2013) 37: 406-414.
(8) Vogt M, Kunath K and Dressman JB. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur. J. of Pharm. and Biopharm.( 2008) 68: 330–337.
(9) Kumar S and Gupta SK. Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note. Arch. Pharm. Res.( 2014) 37: 340-351.
(10) Chauhan H, Hui-Gu C and Atef E. Correlating the behaviour of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions. J. Pharm. Sci.(2013) 102: 1924-1935.
(11) Nokhodchi A, Maghsoodi M, Hassan-Zadeh D and Barzegar-Jalali M. Preparation of agglomerated crystals for improving flowability and compactibility of poorly flowable and compactible drugs and excipients. Powder Technol. (2007) 175: 73-81.
(12) Thati J and Rasmuson Ǻ. On the mechanisms of formation of spherical agglomerates. Eur. J. Pharm. Sci. (2011) 42: 365-379.
(13) Junghanns J and Müller R. Nanocrystal technology, drug delivery and clinical applications. Int. J. Nanomedicine (2008) 3: 295-309.
(14) Borislav T, Christina V, Denitsa A, Yordan Y, Kati A, Virginia T, Ivanka S, Daniela K and Krassimira Y. Improvement of dissolution of poorly soluble glimepiride by loading on two types of mesoporous silica carriers
J. of Solid state Chem. (2018),
https://doi.org/10.1016/j.jssc.2018.12.062
(15) Ribardière A, Tchoreloff P, Couarraze G and Puisieux F. Modification of ketoprofen bead structure produced by the spherical crystallization technique with a two solvent system. Int. J. Pharm. (1996) 144: 195-207.
(16) Katta J and Rasmuson A°.Spherical crystallization of benzoic acid. Int. J. of Pharm. (2008) 348: 61-69.
(17) Viswanathan C, Kulkarni S and Kolwankar D. Spherical agglomeration of mefenamic acid and nabumetone to improve micromeritics and solubility: A Technical Note. AAPS Pharm. Sci. Tech. (2006) 7: E1-E4.
(18) Bhadra S, Kumar M, Jain S, Agrawal S and Agrawal GP. Spherical crystallization of mefenamic acid. Pharm. Technol. (2004) 2: 66-76.
(19) Amaro-González D and Biscans B. Spherical agglomeration during crystallization of an active pharmaceutical ingredient. Powder Technol. (2002) 128: 188-194.
(20) Mahanty S, Sruti J, Niranjan Patra Ch and Bhanoji Rao ME. Particle design of drugs by spherical crystallization techniques. Int. J. of Pharm. Sci. and Nanotechnol. (2010) 3: 912-918.
(21) Yadav AV and Yadav VB. Preparation and evaluation of polymeric carbamazepin spherical crystals by emulsion solvent diffusion technique. Asian J. of Pharm. (2009) 3: 18-25.
(22) Fodor-Kardos A, Toth J and Gyenis J. Preparation of protein loaded chitosan microparticles by combined precipitation and spherical agglomeration. Powder Technol. (2013) 244: 16-25.
(23) Garala(a) KC, Patel JM, Dhingani AP and Dharamsi AT. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: An integrated approach of principal component analysis and Box–Behnken experimental design. Int. J. of Pharm. (2013a) 452: 135-156.
(24) Garala(b) KC, Patel JM, Dhingani AP and Dharamsi AT. Quality by design (QbD) approach for developing agglomerates containing racecadotril and loperamide hydrochloride by crystallo-co-agglomeration. Powder Technol. (2013b) 247: 128-146.
(25) Maghsoodi M, Taghizadeh O, Martin GP and Nokhodchi A. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Powder Technol. (2008) 351: 45-54.
(26) Patil SV and Sahoo SK. Improvement in compressibility, flowability and drug release of glibenclamide by spherical crystallization with additives. Digest J. Nanomater. Biostruct. (2011) 6: 1463-1477.
(27) Carstensen JT. Advanced pharmaceutical solids (2001) (pp. 302, 311). New York, Basel: Marcel Dekker.
(28) Sinko PJ. Martin’s physical pharmacy and pharmaceutical sciences (2006) Philadelphia: Lippincott Williams and Wilkins, p. 558.
(29) Wells J. Pharmaceutical preformulation. The physicochemical properties of drug substances (1988) UK: Ellis Horwood Limited, pp. 209–210.
(30) Aulton ME, Aulton’s pharmaceutics: The design and manufacture of medicines (2007) (pp. 176–7, 449-451). Philadelphia: Churchill Livingstone Elsevier.
(31) Kawakita K and Ludde KH. Some considerations on powder compression equations. Powder Technol (1971) 4: 61–68.
(32) Hu R, Zhu J, Chen G, Sun Y, Mei K and Li S. Preparation of sustained-release simvastatin microspheres by spherical crystallization technique. Asian J of Pharm Sci (2006) 1: 47-52.
(33) Paradkar AR, Pawar AP, Chordiya JK, Patil VB and Ketkar AR. Spherical crystallization of celecoxib. Drug Dev. Ind. Pharm. (2002) 28: 1213-1220.
(34) Kawashima Y, Okumura M and Takenaka H. Spherical crystallization. Direct spherical agglomeration of salicylic acid crystals during crystallization. Science (1982) 216: 1127–1128.
(35) Nokhodchi A and Maghsoodi M. Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique. AAPS Pharm. Sci. Tech. (2008) 9: 54-59.
(36) Bühler V, Polyvinylpyrrolidone Excipients for Pharmaceuticals: Povidone, Crospovidone and Copovidone (2005) (pp. 126-162). Springer-Verlag Berlin: Heidelberg, Germany.
(37) Omidian H and Park K. Swelling agents and devices in oral drug delivery. J. Drug Deliv. Sci. Technol. (2008) 18: 83-93.
(38) Homayouni A , Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Eur J of Pharm Biopharm (2014) 88: 261–274
(39) Kawashima Y, Imai M, Takeuchi H, Yamamoto H and Kamiya K. Development of agglomerated crystals of ascorbic acid by the spherical crystallization technique for direct tableting, and evaluation of their compactibilities. Kona (2002) 20: 251-262.
(40) Lopez MEV, Reyes LN, Anguiano S, Otero-Espinar FJ and Méndez JB. Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. Int. J. Pharm. (1999) 179: 229- 235.
(41) Iwamoto S, Nakagawa K, Sugiura S and Mitsutoshi Nakajima M. Preparation of gelatin microbeads with a narrow size distribution using microchannel emulsification. AAPS Pharm. Sci. Tech. (2002) 3: 1-5.